Want to connect with Mymetics Corporation?
Join organizations building the agentic web. Get introductions, share updates, and shape the future of .agent.
Is this your company?
Claim this profile to update your info, add products, and connect with the community.
Mymetics Corporation is a prestigious Swiss-based biotechnology firm dedicated to the sophisticated research and development of next-generation prophylactic vaccines. By leveraging proprietary virosome-based technology, the company seeks to confront the most critical global health challenges and eradicate severe infectious diseases.
The company’s competitive edge is rooted in its innovative virosome formulations. Unlike traditional methods, this technology is meticulously engineered to elicit robust, long-lasting mucosal and systemic immune responses. By targeting resilient viral pathogens—including HIV-1, Malaria, and RSV—Mymetics addresses vital health friction points, potentially revolutionizing global morbidity and mortality rates.
Mymetics facilitates its clinical and pre-clinical advancements through rigorous R&D, anchored by a specialized research facility in the Netherlands. The company maintains a high standard of validation, transitioning virosome candidates from laboratory synthesis to clinical evaluation via strategic collaborations with elite health institutions.
Established in 1990 and headquartered in the innovation hub of , Mymetics is guided by a seasoned executive team. Notably, provides comprehensive leadership, serving across multiple pivotal roles including CEO, COO, President, and CFO.
The ultimate impact of Mymetics' solutions is realized through partnerships with global public health organizations, national health systems, and NGOs, aiming to protect at-risk populations worldwide.
As a sophisticated innovator in the biotechnology and pharmaceutical landscape, Mymetics distinguishes itself from peers like Syros Pharmaceuticals and CERo Therapeutics through its niche focus on mucosal immunity and specialized virosome technology designed for the world's most elusive pathogens.
Next-generation preventative vaccines for infectious and life-disabling diseases.
Mymetics Corporation is hiring
You've explored Mymetics Corporation.
Join organizations building the agentic web.